ClinicalTrials.Veeva
Menu

Find clinical trials for Prostate Cancer in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Prostatic Cancer
Cancer
Breast Cancer
Ovarian Cancer
Endometrial Cancer
Neoplasm Metastasis
Non-Small-Cell Lung Carcinoma

Prostate Cancer trials near Nashville, TN, USA:

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...

Enrolling
Castration Resistant Prostatic Cancer
Metastatic Castration-resistant Prostate Cancer
Biological: JANX007
Drug: Darolutamide

Phase 1

Janux Therapeutics

Nashville, Tennessee, United States and 34 other locations

Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potentia ...

Enrolling
Metastatic Castration Resistant Prostate Cancer
Metastatic Castration-sensitive Prostate Cancer
Drug: prednisone
Drug: PRL-02 injection

Phase 1

Astellas
Astellas

Nashville, Tennessee, United States and 24 other locations

The aim for this study is to investigate the ability of 64Cu-SAR-bisPSMA PET/CT to detect recurrence of prostate cancer...

Enrolling
Prostate Cancer Patients Who Have Brachytherapy Seed Implant
Prostate Cancer Patients Treated by Radiotherapy
Drug: 64Cu-SAR-bisPSMA

Phase 3

Clarity Pharmaceuticals

Nashville, Tennessee, United States and 26 other locations

Assessment of the safety and efficacy of HLD-0915 as monotherapy in patients with metastatic castration resistant prostate cancer (...

Enrolling
Prostate Cancer (Adenocarcinoma)
Prostate Cancer Metastatic Disease
Drug: HLD-0915

Phase 1, Phase 2

Halda Therapeutics OpCo, Inc.

Nashville, Tennessee, United States and 10 other locations

A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...

Active, not recruiting
Prostate Cancer Metastatic
Drug: ARV-766 + Abiraterone Part C&D
Drug: ARV-766 Part A&B

Phase 1, Phase 2

Novartis
Novartis

Nashville, Tennessee, United States and 22 other locations

The overall aim of the trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of AMG 509 (monotherapy and in combination with abira...

Enrolling
Prostate Cancer
Drug: AMG 509
Drug: Abiraterone

Phase 1

Amgen
Amgen

Nashville, Tennessee, United States and 56 other locations

The main objective of the trial is to evaluate the safety and tolerability of xaluritamig in combination with darolutamide or abiraterone.

Enrolling
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Drug: Darolutamide
Drug: Abiraterone

Phase 1

Amgen
Amgen

Nashville, Tennessee, United States and 10 other locations

clinical efficacy in participants with metastatic hormone-sensitive prostate cancer (mHSPC) by progression-free survival.The resear...

Active, not recruiting
Metastatic Hormone-sensitive Prostate Cancer
Other: ADT
Drug: Darolutamide (BAY1841788, Nubeqa)

Phase 2

Bayer
Bayer

Nashville, Tennessee, United States and 32 other locations

The primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's...

Enrolling
Metastatic Castration-resistant Prostate Cancer
Drug: Xaluritamig
Drug: Docetaxel

Phase 3

Amgen
Amgen

Nashville, Tennessee, United States and 93 other locations

plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...

Active, not recruiting
Prostate Cancer
Drug: Placebo
Drug: Prednisone

Phase 2, Phase 3

Lilly
Lilly

Nashville, Tennessee, United States and 112 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems